| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | BRD-K33199242 | CTRPv2 | pan-cancer | AAC | -0.099 | 0.009 |
| mRNA | clofarabine | CTRPv2 | pan-cancer | AAC | 0.076 | 0.01 |
| mRNA | BRD-K80183349 | CTRPv2 | pan-cancer | AAC | -0.084 | 0.01 |
| mRNA | Gemcitabine | gCSI | pan-cancer | AAC | 0.15 | 0.01 |
| mRNA | LRRK2-IN-1 | CTRPv2 | pan-cancer | AAC | -0.092 | 0.01 |
| mRNA | lapatinib | CTRPv2 | pan-cancer | AAC | -0.09 | 0.01 |
| mRNA | austocystin d | CTRPv2 | pan-cancer | AAC | -0.092 | 0.01 |
| mRNA | Topotecan | CCLE | pan-cancer | AAC | 0.1 | 0.02 |
| mRNA | ML083 | CTRPv2 | pan-cancer | AAC | -0.095 | 0.02 |
| mRNA | BRD-K20514654 | CTRPv2 | pan-cancer | AAC | -0.13 | 0.02 |